[HTML][HTML] Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review
Objective Summarize the comparative effectiveness of oral non-steroidal anti-inflammatory
drugs (NSAIDs) and opioids in reducing knee osteoarthritis (OA) pain. Methods Two …
drugs (NSAIDs) and opioids in reducing knee osteoarthritis (OA) pain. Methods Two …
Celecoxib for osteoarthritis
Background Osteoarthritis (OA) is the most common form of arthritis and is caused by
degeneration of the joint cartilage and growth of new bone, cartilage and connective tissue …
degeneration of the joint cartilage and growth of new bone, cartilage and connective tissue …
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
Background Glucosamine and chondroitin sulfate are used to treat osteoarthritis. The
multicenter, double-blind, placebo-and celecoxib-controlled Glucosamine/chondroitin …
multicenter, double-blind, placebo-and celecoxib-controlled Glucosamine/chondroitin …
Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials
JM Bjordal, A Klovning, AE Ljunggren… - European Journal of Pain, 2007 - Elsevier
BACKGROUND: Pain is the most debilitating symptom in osteoarthritis of the knee (OAK).
AIM AND METHODS: To determine the short-term pain-relieving effects of seven commonly …
AIM AND METHODS: To determine the short-term pain-relieving effects of seven commonly …
Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials
ContextAdverse effects of selective cyclooxygenase 2 (COX-2) inhibitors on renal events
and arrhythmia have been controversial, with suggestions of a class effect. ObjectiveTo …
and arrhythmia have been controversial, with suggestions of a class effect. ObjectiveTo …
Effectiveness and implications of alternative placebo treatments: a systematic review and network meta-analysis of osteoarthritis trials
RR Bannuru, TE McAlindon, MC Sullivan… - Annals of internal …, 2015 - acpjournals.org
Background: Placebo controls are essential in evaluating the effectiveness of medical
treatments. Although it is unclear whether different placebo interventions for osteoarthritis …
treatments. Although it is unclear whether different placebo interventions for osteoarthritis …
Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis
PL McCormack - Drugs, 2011 - Springer
Celecoxib (Celebrex®) was the first cyclo-oxygenase (COX)-2 selective inhibitor (coxib) to
be introduced into clinical practice. Coxibs were developed to provide anti-inflammatory …
be introduced into clinical practice. Coxibs were developed to provide anti-inflammatory …
Safety of cyclooxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and meta-analysis
Objective Our aim was to assess the safety of cyclooxygenase-2 (COX-2) inhibitors in the
management of osteoarthritis (OA) in a systematic review and meta-analysis of randomized …
management of osteoarthritis (OA) in a systematic review and meta-analysis of randomized …
Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review
A Rostom, K Muir, C Dubé, E Jolicoeur… - Clinical …, 2007 - Elsevier
Background & Aims: Nonselective non-steroidal anti-inflammatory drugs (NSAIDs) and
cyclooxygenase-2 inhibitors (COX-2s) are used to treat a variety of arthritic and inflammatory …
cyclooxygenase-2 inhibitors (COX-2s) are used to treat a variety of arthritic and inflammatory …
Clinical use and pharmacological properties of selective COX-2 inhibitors
S Shi, U Klotz - European journal of clinical pharmacology, 2008 - Springer
Abstract Selective COX-2 inhibitors (coxibs) are approved for the relief of acute pain and
symptoms of chronic inflammatory conditions such as osteoarthritis (OA) and rheumatoid …
symptoms of chronic inflammatory conditions such as osteoarthritis (OA) and rheumatoid …